TRATTAMENTO CON STREPTOCHINASI IN UN CASO DI CRIOFIBRINOGENEMIA ASSOCIATO A VASCULOPATIA ARTERIOSA PERIFERICA = TRAITEMENT PAR LA STREPTOKINASE D'UN CAS DE CRYOFIBRINOGENEMIE ASSOCIE A UNE VASCULOPATHIE ARTERIELLE PERIPHERIQUECIAVARELLA N.1972; TRASFUS. DEL SANGUE; ITAL.; DA. 1972; VOL. 17; NO 2; PP. 166-172; ABS. FR. ANGL. ESP.; BIBL. 15REF.Serial Issue

PRECIPITATING ANTIBODIES TO FACTOR VIII/VON WILLEBRAND FACTOR IN VON WILLEBRAND'S DISEASE: EFFECTS ON REPLACEMENT THERAPYMANNUCCI PM; RUGGERI ZM; CIAVARELLA N et al.1981; BLOOD; ISSN 0006-4971; USA; DA. 1981; VOL. 57; NO 1; PP. 25-31; BIBL. 15 REF.Article

THE EFFECT OF INDOBUFEN (K3920) ON PLATELET AGGREGATION, PLATELET FACTORS 3,4, AND SOME COAGULATION PARAMETERS IN PATIENTS WITH VENOUS THROMBOSISCIAVARELLA N; CORVI G; COVIELLO M et al.1981; CURR. THER. RES.; ISSN 0011-393X; USA; DA. 1981; VOL. 29; NO 3; PART. 2; PP. 503-509; BIBL. 14 REF.Article

FACTOR VII DEFICIENCY: IMMUNOLOGICAL CHARACTERIZATION OF GENETIC VARIANTS AND DETECTION OF CARRIERSMARIANI G; MAZZUCCONI MG; HERMANS J et al.1981; BR. J. HAEMATOL.; ISSN 0007-1048; GBR; DA. 1981; VOL. 48; NO 1; PP. 7-14; BIBL. 19 REF.Article

Efficacy of porcine factor VIII in the management of haemophiliacs with inhibitorsCIAVARELLA, N; ANTONCECCHI, S; RANIERI, P et al.British journal of haematology. 1984, Vol 58, Num 4, pp 641-648, issn 0007-1048Article

Immune status of asymptomatic HIV-infected hemophiliacs : randomized, prospective, two-year comparison of treatment with a high-purity or an intermediate-purity factor VIII concentrateMANNUCCI, P. M; GRINGERI, A; DE BIASI, R et al.Thrombosis and haemostasis. 1992, Vol 67, Num 3, pp 310-313, issn 0340-6245Article

A placebo-controlled study of the effects of chromocarbo-diethylamine on various parameters of platelet function in diabetic patients with vascular diseaseCIAVARELLA, N; ANTONCECCHI, S; D'ELIA, N et al.Current therapeutic research. 1984, Vol 36, Num 2, pp 293-297, issn 0011-393XArticle

Immune tolerance in two high responder, severe hemophilia A patients with inhibitors : the importance of high doses and the duration of the treatmentCIAVARELLA, N; SCHIAVONI, M; FASANO, A et al.Vox sanguinis (Basel. 1956). 1996, Vol 70, pp 72-73, issn 0042-9007, SUP1Conference Paper

Heterogenous phenotypes of platelet and plasma von Willebrand factor in obligatory heterozygotes for severe von Willebrand diseaseMANNUCCI, P. M; LATTUADA, A; CASTAMAN, G et al.Blood. 1989, Vol 74, Num 7, pp 2433-2436, issn 0006-4971Article

Aggregation of human peripheral blood mononuclear cells by calcium ionophore A23187. Comparison with the aggregation of platelets and defective response in Glanzmann's thrombastheniaCERBONE, A. M; DI MINNO, G; MONTEMURRO, P et al.Collection sécurité. 1988, Vol 24, Num 1-2, pp 165-171, issn 0538-4818Article

Hemophilia B with inhibitor: molecular analysis of the subtotal deletion of the factor IX geneHASSAN, H. J; LEONARDI, A; GUERRIERO, R et al.Blood. 1985, Vol 66, Num 3, pp 728-730, issn 0006-4971Article

Frequency of inhibitors in haemophiliacs : authors repliesVERBRUGGEN, . W; NOVAKOVA, I. R. O; WESSELS, J. M. C et al.Lancet (British edition). 1992, Vol 339, Num 8804, issn 0140-6736, 1301 p.Article

High-resolution analysis of von Willebrand factor multimeric composition defines a new variant of type I von Willebrand disease with aberrant structure but presence of all size multimers (type IC)CIAVARELLA, G; CIAVARELLA, N; ANTONCECCHI, S et al.Blood. 1985, Vol 66, Num 6, pp 1423-1429, issn 0006-4971Article

Safety profile of porcine factor VIII and its use as hospital and home-therapy for patients with haemophilia-A and inhibitors : the results of an international surveyHAY, C. R. M; LOZIER, J. N; TEITEL, J et al.Thrombosis and haemostasis. 1996, Vol 75, Num 1, pp 25-29, issn 0340-6245Article

Pharmacokinetics of monoclonally-purified and recombinant factor VIII in patients with severe von Willebrand diseaseMORFINI, M; MANNUCCI, P. M; TENCONI, P. M et al.Thrombosis and haemostasis. 1993, Vol 70, Num 2, pp 270-272, issn 0340-6245Article

Low risk of transmission of the human immunodeficiency virus by a solvent-detergent-treated commercial factor VIII concentrateDI PAOLANTONIO, T; MARIANI, G; CIAVARELLA, N et al.Journal of medical virology. 1992, Vol 36, Num 2, pp 71-74, issn 0146-6615Article

Immunogenicity of a recombinant hepatitis B vaccine in hemophiliacsMANNUCCI, P. M; GRINGERI, A; ZANETTI, A et al.American journal of hematology. 1988, Vol 29, Num 4, pp 211-214, issn 0361-8609Article

Bleeding complications of oral anticoagulant treatment : an inception-cohort-prospective collaborative study (ISCOAT)PALARETI, G; LEALI, N; DEVOTO, G et al.Lancet (British edition). 1996, Vol 348, Num 9025, pp 423-428, issn 0140-6736Article

Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate virusesMANNUCCI, P. M; GDOVIN, S; GRINGERI, A et al.Annals of internal medicine. 1994, Vol 120, Num 1, pp 1-7, issn 0003-4819Article

Prevalence of infection with the hepatitis C virus among Italian hemophiliacs before and after the introduction of virally inactivated clotting factor concentrates : a retrospective evaluationMORFINI, M; MANNUCCI, P. M; BAUDO, F et al.Vox sanguinis (Basel. 1956). 1994, Vol 67, Num 2, pp 178-182, issn 0042-9007Article

Carrier detection in factor VII congenital deficiencyMARIANI, G; HERMANS, J; MANDELLI, F et al.British journal of haematology. 1985, Vol 60, Num 4, pp 687-694, issn 0007-1048Article

Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies : A four-year prospective study from the Italian registryFINAZZI, G; BRANCACCIO, V; BAUDO, F et al.The American journal of medicine. 1996, Vol 100, Num 5, pp 530-536, issn 0002-9343Article

Thrombotic events during oral anticoagulant treatment : Results of the inception-cohort, prospective, collaborative ISCOAT studyPALARETI, G; MANOTTI, C; POGGI, M et al.Thrombosis and haemostasis. 1997, Vol 78, Num 6, pp 1438-1443, issn 0340-6245Article

Porcine factor VIII therapy in patients with congenital hemophilia and inhibitors : efficacy, patient selection, and side effectsHAY, C. R. M; LOZIER, J. N; TEITEL, J et al.Seminars in hematology. 1994, Vol 31, Num 2, pp 20-25, issn 0037-1963, SUP4Conference Paper